Back
ESC Professional Premium Access

SWATH proteomic analysis from the standard care versus celecoxib outcome trial identifies renal biomarkers are associated with early cardiovascular events amongst NSAID users

Session: Clinical and basic science insights in vascular disease
Topic: Biomarkers
Speaker: Doctor R. Vaja (London, GB)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Ricky Vaja

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

6 more presentations in this session

Genome-wide association study on cerebral white-matter hyperintensities in 36,577 individuals

Speaker: Mr J. Jespersen (Copenhagen, DK)

Access
Abstract
Slides
Thumbnail

DNA damage induced by radiation exposure from cardiac catheterization - an analysis in patients and operators

Speaker: Doctor T. Ishida (Fukushima, JP)

Access
Abstract
Slides
Thumbnail

Differential impact of milvexian, an investigational oral FXIa inhibitor vs apixaban and dabigatran on thrombin generation in human donor plasma in vitro

Speaker: Doctor M. Chintala (Spring House, US)

Access
Abstract
Slides
Thumbnail

Preservation of vasculature is beneficial in mitigating cisplatin induced acute kidney injury

Speaker: Associate Professor H. Pan (Saint Louis, US)

Access
Abstract
Slides
Thumbnail

Lack of PI 3-kinase isoform p110alpha impairs SMC differentiation and proliferation and promotes aortic aneurysm formation

Speaker: Doctor M. Vantler (Cologne, DE)

Access
Abstract
Slides
Thumbnail

Access the full session

Clinical and basic science insights in vascular disease

Speakers: Doctor R. Vaja, Mr J. Jespersen, Doctor T. Ishida, Doctor M. Chintala, Associate Professor H. Pan...
Access
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb